SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-017914
Filing Date
2021-01-27
Accepted
2021-01-26 17:45:51
Documents
3
Period of Report
2021-01-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d106954d8k.htm 8-K 20784
2 EX-99.1 d106954dex991.htm EX-99.1 14049
3 GRAPHIC g106954g56z54.jpg GRAPHIC 9981
  Complete submission text file 0001193125-21-017914.txt   44481
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 21555611
SIC: 3841 Surgical & Medical Instruments & Apparatus